MEDX.SWMEDX.SWSIX
Loading
EBITDA Margin Over TimeStable
Percentile Rank57
3Y CAGR+7.5%
5Y CAGR+0.5%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+7.5%/yr
vs -10.8%/yr prior
5Y CAGR
+0.5%/yr
Recent acceleration
Acceleration
+18.3pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
202517.79%+27.3%
202413.97%-0.6%
202314.06%-1.8%
202214.32%-40.8%
202124.19%+39.5%
202017.34%-9.0%
201919.04%-15.7%
201822.58%-